Alliant Quality home page

Substance Use Disorder Treatment Responses to COVID-19

March 18, 2020
for Medicare Beneficiaries or Caregivers
for Behavioral Healthcare Professionals
for Community Members
for Hospital/Pharmacy/Home Health Staff
for Clinicians or Physicians
Covid-19: Potential Implications for Individuals with Substance Use Disorders Pharmacotherapy for Opioid Use Disorder Patients Exposed to Infections and COVID-19 SAMHSA’s COVID-19 Guidance for Opioid Treatment Programs Drug Enforcement Administration’s Guidelines on Use of Telemedicine While Providing Medication Assisted Treatment (MAT) Up-to-date Responses to COVID-19 for the Substance Use Disorder Treatment field